RIPK3 and neoplasm: Results of these queries revealed that expression of RIPK3 is decreased in all stages of CRC (stages I to IV) relative to healthy controls, and that the decline in RIPK3 levels correlates with increased clinical stage or the presence of metastases according to the tumor node metastasis (TNM) staging system (Figure 7B-7D).